Veriheal

FEBRUARY 3, 2022

To participate in Oklahoma’s medical cannabis program, all that patients need to do is meet with a doctor and receive a medical marijuana recommendation. Unlike many other states, Oklahoma did not define a qualifying conditions list. Oklahoma Medical Cannabis Program Prospers.

Programs 52

Programs Seed-To-Sale Wellness and Beauty Compliance 52

Cannabis Law Report

AUGUST 23, 2022

A panel of Commonwealth Court judges has ordered the Wolf administration to reveal how many medical marijuana patients have received approval from a doctor to use cannabis for opioid addiction treatment. Qualifying conditions include anxiety disorders, severe chronic pain and epilepsy. The Altoona Mirror reports.

Data 52

Data Treatment Patients Chronic Pain 52

Nature's Way Medicine

JUNE 4, 2021

Yesterday, the Pennsylvania medical marijuana doctors received an email from the Department of Health’s Marijuana Program office that explained to them that marijuana card appointments must be conducted in-person again. This can be anxiety, PTSD , chronic pain , or many other conditions that you can read about on our Conditions Page.

Marijuana 96

Marijuana Chronic Pain Patients Education 96

MMJ Recs

OCTOBER 5, 2023

With a growing number of MMJ dispensaries, a comprehensive set of laws, and a streamlined process for obtaining a medical marijuana card, the state has become a hub for patients seeking alternative treatments. Whether you’re a potential patient or simply curious about MMJ, we’re here to provide you with all the essential information!

Dispensary 52

Dispensary Patients Treatment Conditions 52

MMJ Recs

NOVEMBER 28, 2022

First of all, let’s go through the application process for your West Virginia MMJ card, which you will need to access the state’s MMJ program. If you’re a resident of the state of West Virginia and you have one of the below qualifying conditions, you can avail of a WV MMJ card : Cancer. How do I get an WV MMJ card? Parkinson’s disease.

Dispensary 52

Dispensary Patients Research and Development Treatment 52

MMJ Recs

FEBRUARY 29, 2024

The landscape of medical marijuana has evolved, offering patients alternative avenues for accessing therapeutic cannabis. Florida allows qualified patients to access medical marijuana, but home cultivation is generally not permitted. Can You Grow Medical Marijuana at Home in Florida?

Cultivation 52

Cultivation Marijuana Environment Patients 52

Veriheal

NOVEMBER 4, 2021

In addition to numerous expansions to the state’s medical marijuana (MMJ) program, the state’s decriminalization of cannabis went into effect in August, beginning the reversal of decades of harm done by the war on drugs. ” Smaller reforms show promise for the future of cannabis in Louisiana as well.

Law 102

Law Decriminalization Advocacy Programs 102

Veriheal

MAY 17, 2021

Many of them even offer the ability for visiting medical cannabis patients from other states to participate in their programs. Theodore happens to also be an addiction expert who refuses to provide treatment to patients that choose to consume cannabis as he believes it interferes with the treatment of other addictions.

Legalization 86

Legalization Pharmaceutical Therapy Chronic Pain 86

Veriheal

DECEMBER 17, 2021

A trio of former hockey players opened a medical marijuana dispensary, Ohio’s medical marijuana program is in for a huge revamp, and a study discovered that cannabis plants may help reduce seizures in children. Ohio Senate Passes Bill To Expand Medical Marijuana Program. Let’s dive into this week’s cannanews. .

Dispensary 98

Dispensary Epilepsy Programs Treatment 98

Cannabis Law Report

AUGUST 3, 2021

Unlike most other ailments, there isn’t a simple test that physicians can use to diagnose a patient with a disorder. The company anticipates launching both programs this year. CannabisFN.com and CFN Media, have been hired to create awareness. Mental health disorders are notoriously difficult to diagnose and treat.

Research and Development 105

Research and Development Data Conditions Therapy 105

SpeedWeed

MARCH 24, 2021

With the Eastern seaboard’s most ambitious Adult Use program primed to explode, New Jersey’s Superior Court Appellate Division (“Appellate Division”) just lifted its “stay” on scoring 18 month old Medical Marijuana applications clearing the way for 5 cultivation, 15 dispensary, and 4 vertically integrated license awards. 24:6I-2, Et Seq.

Programs 52

Programs Business Cannabis Retail 52

Veriheal

MAY 13, 2021

Based on the law’s original language, they were also supposed to begin accepting applications for cultivation and dispensing in June of 2017, with patient cards being issued within the same time frame. 10,773 patients. 47,002 patients. In December of 2019, media reported that over 4,200 lbs. million in sales.

Dispensary 52

Dispensary Cultivation Patients Media 52

Cannabis Law Report

MARCH 3, 2022

Former President Bill Clinton has apparently been hearing a lot about the therapeutic potential of CBD products for pain management lately, and, according to a now-deleted media report, said at a recent conference appearance that broad interest in the topic should spur regulators to develop standards for the cannabinoid. Ganjapreneur report.

Media 52

Media CBD Events THC 52

Cannabis Law Report

DECEMBER 26, 2021

In furtherance of its program, the Company filed US Provisional Patent Application No. “Entheon is proud to be making significant strides in its Entheon IQ™ program,” says Timothy Ko, Chief Executive Officer of Entheon. US Provisional Patent Filed. ” In Vivo Toxicity Assays Completed. .

Research and Development 52

Research and Development Clinical Trials Treatment Packaging 52

Cannabis Law Report

JUNE 2, 2021

TOCC, which is Texas’s only medical cannabis producer with its headquarters in the state, provides thousands of patients across Texas with high-quality medical cannabis to treat chronic or severe conditions as part of the Texas Compassionate Use Program.

Advocacy 75

Advocacy Media Programs Cultivation 75

Cannabis Law Report

JUNE 30, 2021

Yet, despite nearly two billion people with mental illness each year, these conditions are routinely misdiagnosed and inadequately treated. s (CSE: MXT) (OTC: MXTTF) SHAMAN and YMI programs apply machine learning to high-resolution health records to better diagnose mental health disorders. of patients with social anxiety disorder.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

Cannabis Law Report

JUNE 21, 2021

At the moment, Japan does not have any medical cannabis program for their patients. But, as more and more researchers are suggesting the use of marijuana for medical conditions, the restriction might be less strict in the future. Also, many Japanese companies are producing cannabidiol products.

Law 103

Law Seed-To-Sale Research and Development Consumption 103

MMJ Recs

DECEMBER 22, 2023

Public discourse became more nuanced, with patients and advocacy groups championing the cause of medical marijuana as a legitimate and effective treatment option. Studies have shown the efficacy of medical cannabis in treating conditions such as chronic pain, epilepsy, and certain mental health disorders.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

MMJ Recs

APRIL 30, 2024

What was once a stigmatized substance is now increasingly recognized for its therapeutic potential in treating various medical conditions. From the moment a cannabis seed is planted to the point it reaches the hands of a patient, a complex and highly regulated process unfolds.

Cultivation 52

Cultivation Supply Chain Extraction Marijuana 52

The Cannigma

MAY 19, 2021

This was notoriously reflected in the 2020 arrest of a Japanese man and woman for speaking positively about using cannabis in social media posts. Japan does not have a medical cannabis program and does not allow the use of cannabis for patients seeking to treat a medical condition. Shutterstock). Shutterstock).

Law 137

Law Legalization Clinical Trials CBD 137

Cannabis Law Report

JULY 9, 2021

“We are excited to begin cultivation in West Virginia and be one step closer to providing relief to the patients who need it,” said Nicholas Vita, CEO of Columbia Care. As we begin design of Phase 2 of our buildout, we will add more square feet to our facilities to continue to meet the demand of the medical program in West Virginia.”.

Research and Development 105

Research and Development Cultivation Seed-To-Sale Dispensary 105

Cannabis Law Report

APRIL 21, 2022

Publication of this process establishes “prior art,” contributing to MAPS’ patient access strategy by making intellectual property public . 30,000 patient doses) of MDMA in a four-step process beginning with a non-controlled starting material. MEDIA CONTACT . maps.org/newsroom or media@maps.org. 831-429-6362 ext 303.

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

Cannabis Law Report

OCTOBER 22, 2021

–The Company expects to hold a Research & Development event to review,these breakthrough findings in Q4 2021 that will be open to the public, shareholders, analysts and the media– TORONTO, CANADA – October 19, 2021 – Cybin Inc.

Research and Development 52

Research and Development Safety Media Data 52

Cannabis Law Report

NOVEMBER 9, 2021

Delic has been focused on opening locations in secondary cities with considerable demand, in an effort to provide access to the most patients. Delic expects to drive considerable patients to KWC through its media platform and build on the existing national leadership position already in place. Transaction Summary.

Treatment 52

Treatment Therapy Media Access 52

Cannabis Law Report

JULY 24, 2021

Ahmad Doroudian, Chief Executive Officer of BetterLife, stated: “TD-010 is a potential novel therapy to treat debilitating anxiety disorders that show resistance to benzodiazepine and other therapies or require a long-term use and therefore put patients at risk for dependency. Carleton University: Stephen Reid, Media Relations Officer.

Research and Development 98

Research and Development Treatment Therapy Media 98

Cannabis Law Report

JUNE 28, 2021

. “Strategically positioned in a high-traffic, high-population region of Los Angeles , this acquisition enables us to expand our reach to a broader potential audience of consumers and patients with both in-person retail and delivery options.” million , comprised of $8.5 million in cash and $3.0

Retail 105

Retail Events Business Law 105

Cannabis Law Report

JUNE 27, 2019

The Swiss medical program has been far too restrictive, forcing patients to get special authorization from the Federal Office of Public Health. Even with that approval, patients could only get cannabis tinctures and oil, not flower, from a very limited number of dispensaries. ICBC reports.

Chronic Pain 40

Chronic Pain Treatment Patients Programs 40

Cannabis Law Report

AUGUST 19, 2021

The parties entered into a multi-year deal under which TerrAscend will be the sole cultivator and manufacturer of Cookies branded products in New Jersey, subject to certain conditions and regulatory approval. Media Contact: Julie Dietel. Their intention was to create the world’s highest-quality, most innovative cannabis strains.

Cultivation 105

Cultivation Seed-To-Sale Conditions Business 105

Peninsula Alternative Health

NOVEMBER 30, 2017

Once you’re ready to discuss this option, ask the following questions: Does my condition qualify for medical cannabis use? Qualifying conditions in Maryland depend on the severity, if traditional medications have failed, and other stipulations. patients have to pay for it out of pocket. Is medical cannabis safe for me to use?

Treatment 40

Treatment Patients Conditions Tincture 40

Healer

MAY 25, 2021

Here’s what I’d like you to know: Patients report adding THCA and CBDA significantly changed their chronic, inflammation-based conditions including pain and insomnia. Patients report feeling the effects quickly and the benefits continue to build over 30 days . START NOW – CANNABIS DOSAGE PROGRAMS & GUIDES.

Cannabinoids 105

Cannabinoids THC CBD Patients 105

Cannabis Law Report

JULY 20, 2019

In New Jersey, there are nearly 50,000 registered medical marijuana patients and only six Alternative Treatment Centers (ATCs) currently operating. authorizes home delivery to patients. authorizes home delivery to patients. Ability to meet the overall health needs of qualified patients and safety of the public.

Law 40

Law Marijuana Education Cultivation 40

Veriheal

JUNE 9, 2022

Unfortunately, the implementation of a medical cannabis program stalled abruptly the very next day when Governor Chris Christie took office. The patient registry for the medical cannabis program was not opened again until August 9th, 2012. New Jersey’s Medical Cannabis Program Continues to Evolve.

Recreational 21

Recreational Patients Programs Dispensary 21

MedicalJane

DECEMBER 6, 2017

New York Governor Andrew Cuomo marked this past Veteran’s Day by signing a measure that expanded the state’s medical cannabis qualifying conditions to include post-traumatic stress disorder (PTSD). The legislation was sponsored by Senator Diane Savino, a proponent of the inclusion since the program’s infancy.

Programs 47

Programs Legislation Patients Education 47

Cannabis Law Report

JULY 2, 2021

We are honored to directly serve the medical cannabis community in Ohio, which has grown to more than 200,000 registered patients.”. All four dispensaries were issued certificates of operation under Ohio’s Medical Marijuana Control Program in 4Q 2019. Media Contacts Lindsay Wilson. media@col-care.com. Investor Relations.

Dispensary 66

Dispensary Seed-To-Sale Research and Development Cultivation 66

NORML

JUNE 7, 2019

NORML Leaders in the Media. “Adding a condition for which a physician could recommend medical marijuana instead of an opioid is a safer pain management tool that will be useful for both our doctors and patients.” They should be limited only by the patient population in Philadelphia, which is growing every day.”

Decriminalization 118

Decriminalization Patients Legislation Law 118

SpeedWeed

MARCH 14, 2021

In simplest terms, the technology rewards people who complete surveys with cryptocurrency – digital tokens – that they can use for products available through global medical cannabis programs. When it comes to getting products to the final distribution point – the customer or patient – big data and technology are having significant effects.

Data 52

Data Research and Development Marijuana Collective 52

The Cannigma

JULY 1, 2022

These claims influence things like how consumers purchase cannabis or how doctors consult with medical cannabis patients. What if most of it is not based on the level of scientific certainty that cannabis marketing teams and media outlets would have us believe? The cannabis research problem.

Research and Development 108

Research and Development Data THC Clinical Trials 108